A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis

NCT01949051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG: Levocabastine
DRUG: Placebo

Sponsor

GlaxoSmithKline